Tyrosine Kinase


Receptor tyrosine kinases bind to extracellular ligands/growth factors, which promotes receptor dimerization and autophosphorylation of receptor tyrosine residues. This triggers a cascade of downstream events through phosphorylation of intracellular proteins that ultimately transduce the extracellular signal to the nucleus, causing changes in gene expression. Receptor tyrosine kinases include EGFR/ErbB, PDGFR, VEGFR, FGFR and MET subfamilies etc. Dysfunctions in tyrosine phosphorylation are linked to oncogenic transformation. In additions, various adaptor and effector proteins couple to carboxy-terminal of an active kinase. For instance, binding of the GRB2 adaptor protein activates EGFR and MAPK/ERK signaling.
Non-receptor tyrosine kinases involve many well-defined proteins (e.g. the Src family kinases, c-Abl, and Jak kinases) and other kinases which regulates cell growth and differentiation. For example, Src family kinases are curial for activating and inhibitory pathways in the innate immune response.
-
A8489 NVP-BVU972Summary: C-Met inhibitor,potent and selective -
A8528 TAK-285Target: EGFR|HER2Summary: HER2/EGFR(HER1) inhibitor -
A8546 R4061 CitationTarget: SykSummary: SYK inhibitor,potent and ATP-competitive -
A8393 CH5424802Target: ALKSummary: ALK inhibitor,potent and ATP-competitive -
A8418 Dovitinib Dilactic acidSummary: FLT3 inhibitor -
A8548 Fingolimod (FTY720)7 CitationTarget: S1P receptorsSummary: S1P receptors agonist -
A8550 Telatinib (BAY 57-9352)Target: VEGFR|PDGFR|c-KitSummary: VEGFR-2/-3,PDGFR-β and c-Kit inhibitor -
A8555 Vandetanib (ZD6474)Target: VEGFR|EGFRSummary: VEGFR2/EGFR antagonist -
A8557 TAE226 (NVP-TAE226)1 CitationTarget: FAKSummary: FAK inhibitor,potent and ATP-competitive -
A8603 GNF 2Summary: Bcr-Abl inhibitor
